Cardiovascular Function and Risk Factors
Cardiovascular Function and Risk Factors is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 86k research works in it since 1950. 18.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on recommendations and updates for cardiac chamber quantification by echocardiography in adults, with a particular emphasis on evaluating left ventricular diastolic function. It also explores the association of obesity, diabetic cardiomyopathy, and cardiac metabolism with heart failure. The papers cover the use of advanced imaging techniques such as strain imaging and speckle tracking echocardiography to assess cardiac mechanics and function.
- Echocardiography
- Chamber Quantification
- Diastolic Function
- Heart Failure
- Obesity
- Cardiac Metabolism
- Left Ventricular Function
- Strain Imaging
- Diabetic Cardiomyopathy
- Cardiovascular Risk
- Research works
- 86k fractional, since 1950
- In the world top 10%
- 16k per year above
- Top-10% rate
- 18.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +25% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cardiovascular Function and Risk Factors research?
By volume, the United States and China publish the most (4k and 2.4k works in 2022–2025).
By volume, 2022–2025
- 1 United States 4k works
- 2 China 2.4k works
- 3 Italy 930 works
- 4 Japan 845 works
- 5 Germany 709 works
- 6 United Kingdom 707 works
- 7 India 505 works
- 8 Spain 472 works
- 9 France 380 works
- 10 Russia 363 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cardiovascular Function and Risk Factors research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Cardiovascular Function and Risk Factors research, followed by Cleveland Clinic and Mayo Clinic in Arizona.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical College China 104 works
- 2 Cleveland Clinic United States 95 works
- 3 Mayo Clinic in Arizona United States 75 works
- 4 Mayo Clinic United States 71 works
- 5 Brigham and Women's Hospital United States 55 works
- 6 Sichuan University China 49 works
- 7 Harvard University United States 48 works
- 8 Capital Medical University China 47 works
- 9 Johns Hopkins University United States 46 works
- 10 Northwestern University United States 46 works
Who are the leading researchers in Cardiovascular Function and Risk Factors?
The most-cited researchers publishing on Cardiovascular Function and Risk Factors include George A. Mensah, Johan Ärnlöv and Emelia J. Benjamin.
- 1 George A. Mensah 6.8k citations
- 2 Johan Ärnlöv 6.6k citations
- 3 Emelia J. Benjamin 6k citations
- 4 William B. Kannel 5.7k citations
- 5 Valentı́n Fuster 5.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cardiovascular Function and Risk Factors research done?
The largest centres of Cardiovascular Function and Risk Factors research in 2022–2025 are Beijing (China), London (United Kingdom), New York (United States) and Shanghai (China).
Largest cities, 2022–2025
Where is the best place to study Cardiovascular Function and Risk Factors?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Semmelweis University and University of Brescia score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 61.5 | 24.7% | 6.8× | 104 | +71.3% |
| 2 | Semmelweis University Hungary | 60.7 | 13.2% | 11.4× | 35 | +154.1% |
| 3 | University of Brescia Italy | 56.0 | 40.5% | 5.9× | 16 | +54.1% |
| 4 | Wroclaw Medical University Poland | 55.4 | 25.2% | 7.6× | 18 | +153.5% |
| 5 | University of Glasgow United Kingdom | 51.9 | 32.7% | 3.2× | 30 | +98.5% |
| 6 | Institut universitaire de cardiologie et de pneumologie de Québec Canada | 50.1 | 27.1% | 28.4× | 9 | +1.4% |
| 7 | Harvard University United States | 49.2 | 32.8% | 2.4× | 48 | +17.5% |
| 8 | Karolinska Institutet Sweden | 49.1 | 28.8% | 3.6× | 25 | +49.1% |
| 9 | Medical University of Graz Austria | 48.3 | 26.9% | 7.5× | 14 | -7.2% |
| 10 | Capital Medical University China | 47.9 | 22.2% | 5.2× | 47 | +47.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cardiovascular Function and Risk Factors research growing?
Output in 2018–2022 was 25% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cardiovascular Function and Risk Factors.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.